Page 29 - Key Statistics News Today

In this article, Dr. Puja Uppal, Family Medicine, shares her expert insights of the findings and provides Georgia residents with evidence-based recommendations for protecting their health.Why This Matters to YouNew

TIVDAK is the first antibody-drug conjugate to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer Conversion to full approval from...

Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapyTIVDAK is the first antibody-drug conjugate in this patient...

Company Announcement Full approval based on global Phase 3 study demonstrating overall survival benefit of TIVDAK compared to chemotherapy TIVDAK is the first antibody-drug conjugate in this...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Apr 29, 2024--

Primary safety endpoint met; VTP-200 was generally well-tolerated, with no treatment-related grade 3 or higher adverse events or serious AEs . Positive trends in clearance rate for both high-risk HPV...

In this article, Dr. Adriana Davis, Family Medicine, shares her expert insights of the findings and provides Indiana residents with evidence-based recommendations for protecting their health.Why This Matters to YouNew

Karnataka 2nd PUC Result 2024 Live: The Karnataka School Examination and Assessment Board (KESAB) will be releasing the results for the Karnataka Pre

In this article, Dr. Shelandra Bell, Family Medicine, shares her expert insights of the findings and provides Montana residents with evidence-based recommendations for protecting their health.Why This Matters to YouNew

In this article, Dr. Adriana Davis, Family Medicine, shares her expert insights of the findings and provides Vermont residents with evidence-based recommendations for protecting their health.Why This Matters to YouNew